NPS Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results; Two Phase 3 Registration Programs Continue to Advance on Stated Timelines

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported its financial results for the second quarter of 2009. The company reported net income of $2.6 million, or $0.05 per diluted share, for the second quarter of 2009 as compared to net income of $1.2 million, or $0.03 per diluted share, for the second quarter of 2008.